70-Gene Signature in Early-Stage Breast Cancer

Belinda Thewes^{1

2}, Judith Prins¹, Michael Friedlander³

Affiliations

Comment

Belinda Thewes et al. N Engl J Med. 2016.

. 2016 Dec 1;375(22):2199-2200.

doi: 10.1056/NEJMc1612048.

Belinda Thewes^{1

2}, Judith Prins¹, Michael Friedlander³

No abstract available

Comment in

70-Gene Signature in Early-Stage Breast Cancer.
van’t Veer LJ, Rutgers EJT, Piccart M. van’t Veer LJ, et al. N Engl J Med. 2016 Dec 1;375(22):2200-2201. doi: 10.1056/NEJMc1612048. N Engl J Med. 2016. PMID: 27959762 No abstract available.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators. Cardoso F, et al. N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253. N Engl J Med. 2016. PMID: 27557300 Clinical Trial.